Public good vs. real world

There is nothing unusual about medical researchers and corporate executives spending years and many millions of dollars in search of cures or treatments, only to end up at a clinical dead end. It happens all the time. (Full article: 789 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly